Concepedia

Publication | Open Access

A randomized phase II study of pelareorep and docetaxel or docetaxel alone in men with metastatic castration resistant prostate cancer: CCTG study IND 209

DOIFull Paper Access

30

Citations

21

References

2018

Year

Bernhard J. Eigl, Kim Chi, Dongsheng Tu, Sébastien J. Hotte, Eric Winquist, Christopher M. Booth, Christina Canil, Kylea Potvin, Richard Gregg, Scott North,
Oncotarget

Abstract

Pelareorep with docetaxel was tolerable with comparable LPD in both arms but response and survival were inferior and so this combination does not merit further study.

References

YearCitations

Page 1